Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Revenue | 162,000 | 5,000 |
| Research and development | 6m | 6m |
| Selling, general and administrative | 13m | 14m |
| Operating expenses | 20m | 20m |
| Operating income | −19m | −20m |
| Pre-tax income | −18m | −18m |
| Income tax | −2,000 | 3,000 |
| Net income | −18m | −18m |
| Earnings per share | −5.00 | −5.05 |
| Earnings per share, diluted | −5.00 | −5.05 |
| Weighted average shares | 3,647 | 3,596 |
| Weighted average shares, diluted | 3,647 | 3,596 |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15m | 16m | 17m | 17m | 23m | 23m | 25m | 26m |
| Receivables | 0 | 19,000 | 19,000 | 48,000 | — | 0 | 0 | 0 |
| Current assets | 18m | 22m | 28m | 32m | 35m | 38m | 44m | 47m |
| Property, plant and equipment | 55,000 | 61,000 | 68,000 | 57,000 | 62,000 | 67,000 | 62,000 | 68,000 |
| Total assets | 27m | 31m | 38m | 42m | 45m | 50m | 56m | 59m |
| Current liabilities | 2m | 2m | 2m | 2m | 2m | 7m | 7m | 7m |
| Total liabilities | 8m | 9m | 9m | 9m | 9m | 10m | 10m | 10m |
| Equity | 19m | 22m | 29m | 33m | 36m | 40m | 45m | 49m |
| Shares outstanding | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m |
| Shares issued | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m |
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Operating cash flow | −16m | −15m |
| Depreciation and amortisation | 23,000 | 21,000 |
| Capital expenditure | 17,000 | 22,000 |
| Investing cash flow | 9m | 12m |
| Dividends paid | — | 0 |
| Financing cash flow | −873,000 | −129,000 |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)